Paracelsus Medical University Salzburg initiates new research collaboration with Boehringer Ingelheim to investigate the natural regenerative potential of extracellular vesicles derived from human stem cells of the supporting tissue. The application of these vesicles will be studied in musculoskeletal or central nervous system disorders.
For over six years, the PMU has been conducting a research program called “Nanovesicular Therapies” in collaboration with university hospitals and the Paris-Lodron University Salzburg. We have previously reported on this.
The director of the Institute of Experimental Neuroregeneration at PMU Salzburg, Sébastien Couillard-Després, views the collaboration with Boehringer Ingelheim as a “visionary cooperation program that enables the development of innovative approaches for treating complex disorders of the central nervous system and musculoskeletal tissue at PMU.”
Further links
To the article
This might also interest you
19. July 2023
From Mozart to Hightech
In the Austria Picture that aired on ORF 2 on June 11th, our CEO Walter Haas stated, “Salzburg should stand for research, technology, and the future.” The program, produced by the Salzburg Regional Studio, focused on our innovation ecosystem.
21. March 2023
The economy must align with nature
How to use resources efficiently, reuse them, or replace them with natural materials is what circular economy and bioeconomy are concerned with. Experts discussed what it takes to transition to a green economy during a panel at the salz21 innovation festival.
20. March 2023
Hydrogen: This is how we achieve the green transformation
Hydrogen as an energy carrier has great potential. Read an overview of applications and research projects in Salzburg and what hurdles experts still need to overcome for a green transformation.
1. December 2022
This is what you should know about funding
So that you are prepared for the next funding application, we will answer the most important questions about innovation funding here.